# Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD

> **NCT04302181** · EARLY_PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 12 (actual)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Ropivacaine injection

## Key facts

- **NCT ID:** NCT04302181
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-05
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-12-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04302181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04302181, "Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04302181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*